According to our findings, we proposed a schematic presentation of possible mechanisms for the suppressive effects of pyrotinib on proliferation, migration, and invasion in HER2-positive breast cancer cells (Figure 9). This evidence concerns the gene ERBB2 and breast carcinoma.